These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34404892)

  • 1. The order of vasopressor discontinuation and incidence of hypotension: a retrospective cohort analysis.
    Song X; Liu X; Evans KD; Frank RD; Barreto EF; Dong Y; Liu C; Gao X; Wang C; Kashani KB
    Sci Rep; 2021 Aug; 11(1):16680. PubMed ID: 34404892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
    Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norepinephrine vs Vasopressin: Which Vasopressor Should Be Discontinued First in Septic Shock? A Meta-Analysis.
    Wu Z; Zhang S; Xu J; Xie J; Huang L; Huang Y; Yang Y; Qiu H
    Shock; 2020 Jan; 53(1):50-57. PubMed ID: 31008869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.
    Sacha GL; Lam SW; Duggal A; Torbic H; Reddy AJ; Bauer SR
    Pharmacotherapy; 2018 Mar; 38(3):319-326. PubMed ID: 29328496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Hypotension after Discontinuation of Norepinephrine or Arginine Vasopressin in Patients with Septic Shock: a Systematic Review and Meta-Analysis.
    Song JU; Lee J; Park HK; Suh GY; Jeon K
    J Korean Med Sci; 2020 Jan; 35(1):e8. PubMed ID: 31898435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function.
    Taylor A; Jones T; Forehand CC; Smith SE; Dykes H; Newsome AS
    J Pharm Pract; 2022 Dec; 35(6):879-885. PubMed ID: 33977793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study.
    Bauer SR; Aloi JJ; Ahrens CL; Yeh JY; Culver DA; Reddy AJ
    J Crit Care; 2010 Jun; 25(2):362.e7-362.e11. PubMed ID: 19926252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS).
    Jeon K; Song JU; Chung CR; Yang JH; Suh GY
    Crit Care; 2018 May; 22(1):131. PubMed ID: 29784057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
    Bissell BD; Magee C; Moran P; Bastin MLT; Flannery AH
    J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.
    Hammond DA; McCain K; Painter JT; Clem OA; Cullen J; Brotherton AL; Chopra D; Meena N
    J Intensive Care Med; 2019 Oct; 34(10):805-810. PubMed ID: 28618919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database.
    He D; Zhang L; Hu H; Gu WJ; Lu X; Qiu M; Li C; Yin H; Lyu J
    Am J Emerg Med; 2023 Jul; 69():188-194. PubMed ID: 37167890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ; Cadiz ML; Natavio AM
    Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of Norepinephrine and Vasopressin Discontinuation Order in the Recovery Phase of Septic Shock: A Systematic Review and Individual Patient Data Meta-Analysis.
    Hammond DA; Sacha GL; Bissell BD; Musallam N; Altshuler D; Flannery AH; Lam SW; Bauer SR
    Pharmacotherapy; 2019 May; 39(5):544-552. PubMed ID: 30893494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selepressin, a novel selective vasopressin V
    Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L
    Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of cardiovascular instability in patients receiving various vasopressor strategies for peri-intubation hypotension.
    Schmitt CJ; Mattson AE; Brown CS; Mara KC; Cabrera D; Sandefur BJ; Wieruszewski ED
    Am J Emerg Med; 2023 Mar; 65():104-108. PubMed ID: 36603354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK.
    Priyanka P; Chang CH; Chawla LS; Kellum JA; Clermont G; Murugan R
    Shock; 2022 Oct; 58(4):260-268. PubMed ID: 36018286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.
    Wu JY; Stollings JL; Wheeler AP; Semler MW; Rice TW
    Ann Pharmacother; 2017 Jan; 51(1):13-20. PubMed ID: 27630192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
    Xu J; Cai H; Zheng X
    BMC Infect Dis; 2023 Apr; 23(1):199. PubMed ID: 37013474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
    Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
    Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Clinical Outcomes with Initial Norepinephrine or Epinephrine for Hemodynamic Support After Return of Spontaneous Circulation.
    Weiss A; Dang C; Mabrey D; Stanton M; Feih J; Rein L; Feldman R
    Shock; 2021 Dec; 56(6):988-993. PubMed ID: 34172611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.